Moonwalk Biosciences is a genomic medicine company developing precision epigenetic medicines by coupling high-resolution epigenetic profiling with precise engineering tools. The company’s platform uses AI-driven read-and-write technologies and epigenetic editors to modulate gene regulation without altering DNA sequence. Moonwalk aims to reprogram diseased cells to healthy states and target complex diseases by controlling multiple genes in a single step. Its approach emphasizes minimizing off-target effects and toxicities while leaving the underlying genome intact. The company plans to advance its epigenetic profiling and engineering platform and progress its pipeline of epigenetic therapeutics toward the clinic. Moonwalk was co-founded by Alex Aravanis, Arash Jamshidi, Justin Valley, with scientific co-founder Feng Zhang, and is launching with a veteran leadership team focused on translating the platform into clinical products.

Total raised

$57M

Funding rounds

2

Latest round

Seed

Latest activity

Jan 2024